Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Precision BioSciencesCompugenSolid BiosciencesOsiris TherapeuticsAthira Pharma
SymbolNASDAQ:DTILNASDAQ:CGENNASDAQ:SLDBOTCMKTS:OSIRNASDAQ:ATHA
Price Information
Current Price$8.86$8.42$4.99$18.99$17.87
52 Week RangeBuyBuyBuyN/ABuy
MarketRank™
Overall Score1.51.41.80.62.1
Analysis Score3.43.53.40.03.5
Community Score2.82.62.62.03.2
Dividend Score0.00.00.00.00.0
Ownership Score0.80.82.50.83.3
Earnings & Valuation Score0.60.00.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$20.00$20.29$12.40N/A$42.50
% Upside from Price Target125.73% upside140.92% upside148.50% upsideN/A137.83% upside
Trade Information
Market Cap$486.28 million$564.47 million$514.08 million$655.69 million$646.63 million
Beta2.082.521.1N/AN/A
Average Volume998,4041,392,4611,622,366205,753391,508
Sales & Book Value
Annual Revenue$22.24 million$17.80 millionN/AN/AN/A
Price / Sales22.7632.36N/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.72 per share$0.75 per share$1.74 per shareN/AN/A
Price / Book3.2611.23N/AN/AN/A
Profitability
Net Income$-92,880,000.00$-27,340,000.00$-117,220,000.00N/A$-5,160,000.00
EPS($1.91)($0.43)($2.91)N/AN/A
Trailing P/E RatioN/AN/AN/A0.000.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-484.81%N/AN/AN/AN/A
Return on Equity (ROE)-105.74%-26.98%-194.22%N/AN/A
Return on Assets (ROA)-53.08%-23.28%-140.40%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.03%N/AN/A
Current Ratio2.92%16.93%1.84%N/A30.75%
Quick Ratio2.92%16.93%1.84%N/A30.75%
Ownership Information
Institutional Ownership Percentage48.57%63.35%42.73%0.28%66.68%
Insider Ownership Percentage14.30%9.50%31.20%43.40%N/A
Miscellaneous
Employees23168121N/A14
Shares Outstanding57.14 million68.42 million106.88 million34.53 million37.12 million
Next Earnings Date5/21/2021 (Estimated)5/5/2021 (Estimated)5/6/2021 (Estimated)N/A6/24/2021 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableNot Optionable
SourceHeadline
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation ForumAthira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
markets.businessinsider.com - April 21 at 8:17 AM
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation ForumAthira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
finance.yahoo.com - April 21 at 8:17 AM
Athira Pharma (NASDAQ:ATHA) Shares Up 3.2%Athira Pharma (NASDAQ:ATHA) Shares Up 3.2%
americanbankingnews.com - April 20 at 2:44 PM
Athira Pharma (NASDAQ:ATHA) Sees Large Volume IncreaseAthira Pharma (NASDAQ:ATHA) Sees Large Volume Increase
americanbankingnews.com - April 12 at 1:38 PM
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal ...Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal ...
apnews.com - April 8 at 12:07 PM
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair PathwayAthira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway
finance.yahoo.com - April 8 at 12:07 PM
We Think Athira Pharma (NASDAQ:ATHA) Can Afford To Drive Business GrowthWe Think Athira Pharma (NASDAQ:ATHA) Can Afford To Drive Business Growth
nasdaq.com - April 7 at 3:41 PM
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business ...Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business ...
apnews.com - March 26 at 5:13 AM
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business HighlightsAthira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
finance.yahoo.com - March 25 at 7:12 PM
Athira Pharma to Participate in Panel and Corporate Presentations at Life Science Innovation ...Athira Pharma to Participate in Panel and Corporate Presentations at Life Science Innovation ...
apnews.com - March 24 at 9:32 AM
Athira Pharma to Present at Stifel’s 3rd Annual CNS ConferenceAthira Pharma to Present at Stifel’s 3rd Annual CNS Conference
finance.yahoo.com - March 24 at 9:31 AM
Athira Pharma to Participate in Panel and Corporate Presentations at Life Science Innovation Northwest ConferenceAthira Pharma to Participate in Panel and Corporate Presentations at Life Science Innovation Northwest Conference
finance.yahoo.com - March 23 at 8:27 AM
Companies Like Athira Pharma (NASDAQ:ATHA) Are In A Position To Invest In GrowthCompanies Like Athira Pharma (NASDAQ:ATHA) Are In A Position To Invest In Growth
finance.yahoo.com - March 18 at 8:34 AM
Athira Pharma Announces Appointment of Barbara Kosacz to its Board of DirectorsAthira Pharma Announces Appointment of Barbara Kosacz to its Board of Directors
finance.yahoo.com - March 8 at 8:29 AM
Athira Pharma Announces Appointment of Barbara Kosacz to its Board of DirectorsAthira Pharma Announces Appointment of Barbara Kosacz to its Board of Directors
finance.yahoo.com - March 8 at 8:29 AM
Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences ConferenceAthira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference
finance.yahoo.com - March 2 at 9:46 AM
Athira Pharma Announces Exercise of Underwriters Option to Purchase Additional SharesAthira Pharma Announces Exercise of Underwriters' Option to Purchase Additional Shares
marketwatch.com - February 11 at 1:35 PM
Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional SharesAthira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - February 10 at 7:28 PM
Bullish or Bearish for Athira Pharma, Inc. (NASDAQ:ATHA) in 2021Bullish or Bearish for Athira Pharma, Inc. (NASDAQ:ATHA) in 2021
stocksregister.com - February 6 at 6:39 PM
Why Athira Pharma Stock Dropped TodayWhy Athira Pharma Stock Dropped Today
finance.yahoo.com - January 24 at 12:13 AM
Athira Pharma Announces Pricing of Public Offering of Common StockAthira Pharma Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 20 at 10:18 PM
Athira Pharma Announces Proposed Public Offering of Common StockAthira Pharma Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 19 at 5:55 PM
Is ATHA A Good Stock To Buy According To Hedge Funds?Is ATHA A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 19 at 2:19 AM
What Type Of Shareholders Make Up Athira Pharma, Inc.s (NASDAQ:ATHA) Share Registry?What Type Of Shareholders Make Up Athira Pharma, Inc.'s (NASDAQ:ATHA) Share Registry?
finance.yahoo.com - December 18 at 6:18 AM
Athira Pharma Announces Appointment of Kelly A. Romano to its Board of DirectorsAthira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors
finance.yahoo.com - December 14 at 8:04 AM
DateCompanyBrokerageAction
3/18/2021Precision BioSciencesJonestradingReiterated Rating
1/29/2021Precision BioSciencesJPMorgan Chase & Co.Boost Price Target
12/15/2020Precision BioSciencesHC WainwrightReiterated Rating
11/23/2020Precision BioSciencesStifel NicolausBoost Price Target
8/17/2020Precision BioSciencesBarclaysReiterated Rating
6/8/2020Precision BioSciencesWilliam BlairReiterated Rating
4/2/2020Precision BioSciencesThe Goldman Sachs GroupDowngrade
8/9/2019Precision BioSciencesBTIG ResearchInitiated Coverage
4/22/2019Precision BioSciencesJefferies Financial GroupInitiated Coverage
4/13/2021CompugenSVB LeerinkLower Price Target
3/17/2021CompugenOppenheimerReiterated Rating
5/26/2020CompugenJMP SecuritiesInitiated Coverage
4/28/2020CompugenSunTrust BanksBoost Price Target
4/22/2020CompugenRoth CapitalInitiated Coverage
2/21/2020CompugenCantor FitzgeraldReiterated Rating
3/22/2021Solid BiosciencesCredit Suisse GroupBoost Price Target
3/22/2021Solid BiosciencesChardan CapitalBoost Price Target
5/21/2020Solid BiosciencesNomuraReiterated Rating
12/18/2019Solid BiosciencesNomura SecuritiesBoost Price Target
10/11/2019Solid BiosciencesEvercore ISIInitiated Coverage
8/29/2019Solid BiosciencesCitigroupDowngrade
(Data available from 4/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.